SL
VRTX icon

Savior LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Savior LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed -$3K – 219
2021
Q3 		$3K Sell
17
-100
-85% -$19.5K ﹤0.01% 153
2021
Q2 		$24K Hold
117
– – 0.02% 262
2021
Q1 		$25K Sell
117
-19
-14% -$4.17K 0.03% 253
2020
Q4 		$32K Hold
136
– – 0.03% 211
2020
Q3 		$37K Hold
136
– – 0.04% 162
2020
Q2 		$39K Buy
136
+17
+14% +$4.61K 0.05% 144
2020
Q1 		$28K Sell
119
-5
-4% -$1.15K 0.03% 162
2019
Q4 		$27K Buy
+124
New +$25.1K 0.04% 252

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Savior LLC's VRTX Position: Q4 2021 in Review

Savior LLC sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 17 shares — an estimated $3K sold.

Savior LLC first reported a position in VRTX in Q4 2019 and held it in 8 quarters. The position peaked at $39K in Q2 2020. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

  • Savior LLC reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Savior LLC sold 17 Vertex Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Savior LLC first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • Savior LLC's Vertex Pharmaceuticals position peaked at $39K in Q2 2020.
  • 1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Savior LLC's 13F filing for Q4 2021, filed 3 Feb 2022.